Cardiovascular outcome studies with novel antidiabetes agents: scientific and operational considerations.

MLA

Hirshberg, Boaz, and Arie Katz. “Cardiovascular Outcome Studies with Novel Antidiabetes Agents: Scientific and Operational Considerations.” Diabetes Care, vol. 36 Suppl 2, Aug. 2013, pp. S253–58. EBSCOhost, https://doi.org/10.2337/dcS13-2041.

APA

Hirshberg, B., & Katz, A. (2013). Cardiovascular outcome studies with novel antidiabetes agents: scientific and operational considerations. Diabetes Care, 36 Suppl 2, S253–S258. https://doi.org/10.2337/dcS13-2041

Chicago

Hirshberg, Boaz, and Arie Katz. 2013. “Cardiovascular Outcome Studies with Novel Antidiabetes Agents: Scientific and Operational Considerations.” Diabetes Care 36 Suppl 2 (August): S253–58. doi:10.2337/dcS13-2041.